Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
California just passed a law to rein in drug prices. Here’s why it’s unlikely to make much difference
Stat
Tue, 10/24/17 - 09:04 am
California
drug pricing
Gilead Slaps Mega-Price on Its Newly Approved CAR-T
Motley Fool
Fri, 10/20/17 - 09:04 am
Gilead Sciences
CAR-T
drug pricing
Yescarta
Kite Pharma
Despite increased spending, orphan drugs still small piece of US medicines market
Biopharma Dive
Thu, 10/19/17 - 09:19 am
orphan drugs
drug pricing
Many questions, few answers in Senate hearing on opaque US drug pricing system
Endpoints
Tue, 10/17/17 - 08:27 pm
drug pricing
Senate
PBMs
We may soon have our first $1 million drug. Who will pay for it? And how?
Stat
Sat, 10/14/17 - 11:04 am
gene therapy
drug pricing
Spark Therapeutics
Luxturna
Here Come More Gene Therapies -- And More Pricing Debates
Forbes
Wed, 10/11/17 - 10:03 am
gene therapies
drug pricing
Luxturna
Spark Therapeutics
Kymriah
Novartis
California enacts drug pricing transparency bill
Biopharma Dive
Tue, 10/10/17 - 11:32 pm
California
drug pricing
transparency
As CAR-T launch ramps up in U.S., Novartis' Narasimhan looks to convince Japan on performance-based pricing
Fierce Pharma
Thu, 10/5/17 - 06:16 pm
Novartis
CAR-T
Vas Narasimhan
Japan
drug pricing
performance-based pricing
Deconstructing Drug Pricing Strategy for Big Pharma
Drug Patent Watch
Thu, 10/5/17 - 09:43 am
drug pricing
Big Pharma
consumers
AstraZeneca, Tesaro and Clovis need to slash the cost of PARP meds, watchdog says
Fierce Pharma
Mon, 10/2/17 - 10:10 pm
AstraZeneca
Tesaro
Clovis Oncology
PARP inhibitors
drug pricing
ovarian cancer
Lynparza
Zejula
Rubraca
Big Pharma Doesn't Want Health Outcomes To Sway Pricing -- At Least Not Yet
Forbes
Fri, 09/29/17 - 11:53 am
Big Pharma
drug pricing
gene therapy
Novartis
Kymriah
Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages
RAPS.org
Thu, 09/28/17 - 11:12 am
FDA
drug approvals
drug pricing
Pharma's pricing pledges? Maybe they weren't such a good idea in the first place, experts say
Fierce Pharma
Thu, 09/28/17 - 09:55 am
drug pricing
AbbVie
What pledge? AbbVie executives may back off their vow to limit price hikes: report
Fierce Pharma
Mon, 09/25/17 - 07:34 pm
AbbVie
drug pricing
Premium price for Novartis' CAR-T sparks pushback from top PBM
BioPharma Dive
Mon, 09/25/17 - 07:23 pm
Novartis
Kymriah
CAR-T
drug pricing
Express Scripts
PBMs
Express Scripts' Miller Backs New Pricing Models for CAR-T
BioCentury
Fri, 09/22/17 - 09:13 am
Express Scripts
drug pricing
CAR-T
gene therapy
Kymriah
New pharma CEOs to face payer, pricing challenges
Medical Marketing and Media
Thu, 09/21/17 - 10:15 pm
Pharma CEOs
Novartis
Teva Pharmaceutical
Kåre Schultz
Vasant Narasimham
payers
drug pricing
Will Amazon really get into drug sales? It's in talks with PBMs already, report says
Fierce Pharma
Thu, 09/21/17 - 11:30 am
Amazon
PBMs
supply chain
drug pricing
Judge denies PhRMA, BIO jab at Nevada law
BioPharma Dive
Wed, 09/20/17 - 11:05 pm
PhRMA
BIO
Nevada
drug pricing
Remicade: A Case Study in How U.S. Pricing and Reimbursement Curb Adoption of Biosimilars
Drug Channels
Wed, 09/20/17 - 09:05 am
drug pricing
reimbursement
Remicade
biosimilars
Janssen
Inflectra
Pfizer
Renflexis
Merck
Pages
« first
‹ previous
…
49
50
51
52
53
54
55
56
57
…
next ›
last »